Terveystalo Oy (TTALO) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Terveystalo Oy (TTALO) has a cash flow conversion efficiency ratio of 0.057x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€31.20 Million ≈ $36.48 Million USD) by net assets (€544.80 Million ≈ $636.93 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See TTALO net asset quality index to measure how much of total assets are equity-financed.
Terveystalo Oy - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Terveystalo Oy's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check TTALO cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Terveystalo Oy Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Terveystalo Oy ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Starlake Bioscience Co Inc Zhaoqing Guangdong
SHG:600866
|
0.149x |
|
Shanghai Film Co Ltd
SHG:601595
|
0.000x |
|
Tarkett SA
PA:TKTT
|
-0.097x |
|
Kuangda Technology Group Co Ltd
SHE:002516
|
0.058x |
|
Japfa Comfeed Indonesia Tbk
JK:JPFA
|
0.005x |
|
Huafon Microfibre Shanghai Co
SHE:300180
|
0.029x |
|
SMA SOLAR T. UNSP.ADR/01
F:S93
|
-0.017x |
|
Time Technoplast Limited
NSE:TIMETECHNO
|
0.087x |
Annual Cash Flow Conversion Efficiency for Terveystalo Oy (2014–2024)
The table below shows the annual cash flow conversion efficiency of Terveystalo Oy from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see TTALO market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €548.20 Million ≈ $640.90 Million |
€223.70 Million ≈ $261.53 Million |
0.408x | +33.11% |
| 2023-12-31 | €515.40 Million ≈ $602.56 Million |
€158.00 Million ≈ $184.72 Million |
0.307x | +28.80% |
| 2022-12-31 | €592.00 Million ≈ $692.11 Million |
€140.90 Million ≈ $164.73 Million |
0.238x | -25.76% |
| 2021-12-31 | €608.90 Million ≈ $711.87 Million |
€195.20 Million ≈ $228.21 Million |
0.321x | +27.50% |
| 2020-12-31 | €571.50 Million ≈ $668.14 Million |
€143.70 Million ≈ $168.00 Million |
0.251x | -21.61% |
| 2019-12-31 | €541.20 Million ≈ $632.72 Million |
€173.60 Million ≈ $202.96 Million |
0.321x | +63.19% |
| 2018-12-31 | €511.80 Million ≈ $598.35 Million |
€100.60 Million ≈ $117.61 Million |
0.197x | +28.41% |
| 2017-12-31 | €457.30 Million ≈ $534.63 Million |
€70.00 Million ≈ $81.84 Million |
0.153x | -45.02% |
| 2016-12-31 | €232.27 Million ≈ $271.54 Million |
€64.67 Million ≈ $75.61 Million |
0.278x | +2.38% |
| 2015-12-31 | €220.38 Million ≈ $257.65 Million |
€59.93 Million ≈ $70.07 Million |
0.272x | +1.91% |
| 2014-12-31 | €218.47 Million ≈ $255.42 Million |
€58.30 Million ≈ $68.16 Million |
0.267x | -- |
About Terveystalo Oy
Terveystalo Oyj provides occupational healthcare services in Finland, Sweden, and Estonia. It operates through three segments: Healthcare Services, Portfolio Businesses, and Sweden. The company offers general practice and specialist medical care, diagnostic, outpatient surgery, dental, and other adjacent services; healthcare outsourcing and staffing services; child welfare services; and oral heal… Read more